122 related articles for article (PubMed ID: 27012120)
21. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
[TBL] [Abstract][Full Text] [Related]
22. Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities.
Johansson H; Bjelkenkrantz K; Darlin L; Dilllner J; Forslund O
PLoS One; 2015; 10(4):e0124460. PubMed ID: 25893988
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.
Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
Virchows Arch; 2009 Dec; 455(6):505-15. PubMed ID: 19908064
[TBL] [Abstract][Full Text] [Related]
24. Differential DNA copy number aberrations in the progression of cervical lesions to invasive cervical carcinoma.
Oh EK; Kim YW; Kim IW; Liu HB; Lee KH; Chun HJ; Park DC; Oh EJ; Lee AW; Bae SM; Ahn WS
Int J Oncol; 2012 Dec; 41(6):2038-46. PubMed ID: 23023522
[TBL] [Abstract][Full Text] [Related]
25. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
[TBL] [Abstract][Full Text] [Related]
26. Coexistence of low and high grade squamous intraepithelial lesions of the cervix: morphologic progression or multiple papillomaviruses?
Park J; Sun D; Genest DR; Trivijitsilp P; Suh I; Crum CP
Gynecol Oncol; 1998 Sep; 70(3):386-91. PubMed ID: 9790792
[TBL] [Abstract][Full Text] [Related]
27. Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2.
Pajtler M; Milicić-Juhas V; Milojković M; Topolovec Z; Curzik D; Mihaljević I
Coll Antropol; 2010 Mar; 34(1):81-6. PubMed ID: 20432737
[TBL] [Abstract][Full Text] [Related]
28. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
29. The relationship between syntactic structure analysis features, histological grade and high-risk HPV DNA in cervical intraepithelial neoplasia.
Kruse AJ; Buhr-Wildhagen S; Janssen EA; Baak JP
Cell Oncol; 2004; 26(3):135-41. PubMed ID: 15371649
[TBL] [Abstract][Full Text] [Related]
30. Prediction value with a novel and accurate tissue-based human papillomavirus detection method in low-grade squamous intraepithelial lesions.
Wang H; He Z; Han X; Zhang D; Zhang S
Cancer Med; 2022 Jul; 11(13):2576-2587. PubMed ID: 35343653
[TBL] [Abstract][Full Text] [Related]
31. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
Okadome M; Saito T; Tanaka H; Nogawa T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K;
J Obstet Gynaecol Res; 2014 Feb; 40(2):561-9. PubMed ID: 24147758
[TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical values of HPV L1 and p16INK4a protein in uterine cervical lesions].
Song Y; Li Q; Li L; Chen W; Shen GH; Qiao YL; Zhang X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):352-5. PubMed ID: 22883455
[TBL] [Abstract][Full Text] [Related]
33. Age distribution of HPV genotypes in cervical intraepithelial neoplasia.
Sideri M; Igidbashian S; Boveri S; Radice D; Casadio C; Spolti N; Sandri MT
Gynecol Oncol; 2011 Jun; 121(3):510-3. PubMed ID: 21396686
[TBL] [Abstract][Full Text] [Related]
34. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
[TBL] [Abstract][Full Text] [Related]
35. SOX2 expression in the pathogenesis of premalignant lesions of the uterine cervix: its histo-topographical distribution distinguishes between low- and high-grade CIN.
Moshi JM; Ummelen M; Broers JLV; Smedts F; Van de Vijver KK; Cleutjens JPM; Litjens RJNTM; Ramaekers FCS; Hopman AHN
Histochem Cell Biol; 2022 Dec; 158(6):545-559. PubMed ID: 35945296
[TBL] [Abstract][Full Text] [Related]
36. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
[TBL] [Abstract][Full Text] [Related]
37. The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3.
Litjens RJ; Van de Vijver KK; Hopman AH; Ummelen MI; Speel EJ; Sastrowijoto SH; Van Gorp T; Slangen BF; Kruitwagen RF; Krüse AJ
Hum Pathol; 2014 Feb; 45(2):221-6. PubMed ID: 24439220
[TBL] [Abstract][Full Text] [Related]
38. Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections.
Depuydt CE; Jonckheere J; Berth M; Salembier GM; Vereecken AJ; Bogers JJ
Cancer Med; 2015 Aug; 4(8):1294-302. PubMed ID: 25991420
[TBL] [Abstract][Full Text] [Related]
39. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
[TBL] [Abstract][Full Text] [Related]
40. Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trials.
Mills AM; Paquette C; Castle PE; Stoler MH
Am J Surg Pathol; 2015 May; 39(5):611-7. PubMed ID: 25602791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
